TS
AZN icon

Triglav Skladi’s AstraZeneca AZN Stock Holding History

Triglav Skladi’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.26M Buy
38,280
+1,662
+5% +$313K 0.38% 50
2026
Q1 		$7.22M Sell
36,618
-13,500
-27% -$2.6M 0.51% 42
2025
Q4 		$9.21M Buy
50,118
+18
+0% +$3.16K 0.58% 38
2025
Q3 		$7.69M Buy
50,100
+5,609
+13% +$849K 0.5% 43
2025
Q2 		$6.22M Sell
44,491
-577
-1% -$80.9K 0.45% 46
2025
Q1 		$6.62M Buy
45,068
+3,197
+8% +$463K 0.55% 45
2024
Q4 		$5.49M Buy
+41,871
New +$5.86M 0.43% 49

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Triglav Skladi's AZN Position: Q2 2026 in Review

Triglav Skladi increased its AstraZeneca (AZN) stake by 4.5% in Q2 2026, buying an estimated $313K and bringing the position to 38,280 shares worth $7.26M. The position accounts for 0.38% of the portfolio, ranked #50.

Triglav Skladi first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.21M in Q4 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Triglav Skladi held 38,280 shares of AstraZeneca worth $7.26M as of Q2 2026.
  • Triglav Skladi bought 1,662 AstraZeneca shares in Q2 2026, an estimated $313K.
  • AstraZeneca made up 0.38% of Triglav Skladi's portfolio in Q2 2026, its #50 holding.
  • Triglav Skladi first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's AstraZeneca position peaked at $9.21M in Q4 2025.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.